CervoMed Inc. carries no debt; cash flow comfortably covers obligations.

CervoMed Inc.'s free cash flow has decreased 41.86% from $-16.53M last year to $-23.45M, signaling decreasing performance

CervoMed Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

CervoMed Inc. has insufficient data to evaluate this check.

CervoMed Inc. has a net cash position, so leverage is healthy.

CervoMed Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

CervoMed Inc. has insufficient data to evaluate this check.

CervoMed Inc.'s short-term assets of $22.56M exceed its short-term liabilities of $4.66M

CervoMed Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

CervoMed Inc.'s return on equity of -156.02%, is lower than 15.00%, indicating bad performance

CervoMed Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

CervoMed Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

CervoMed Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

CervoMed Inc. has negative free cash flow, indicating cash burn

CervoMed Inc.'s yearly earnings has decreased 65.53% since last year from $-16.29M to $-26.97M, signaling decreasing performance

CervoMed Inc.'s yearly revenue has decreased 58.86% since last year from $9.74M to $4.01M, signaling decreasing performance

ROIC -123.15% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

CervoMed Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

CervoMed Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

CervoMed Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

CervoMed Inc. has insufficient data to evaluate this check.

CervoMed Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

CervoMed Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

CervoMed Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

CervoMed Inc. has insufficient data to evaluate this check.

CervoMed Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

CervoMed Inc. has a price-to-book ratio of 1.28x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

CervoMed Inc. has a price-to-sales ratio of 90.79x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue